Every vision has its story, and ours began more than 60 years ago. Since then, our innovations and achievements have become landmarks in dentistry worldwide. Straumann began as a family-owned institute, grew into a publicly-owned holding, and today comprises a number of leading and talented companies around the world. Our vision has always been to create more than just smiles, but lasting confidence for dentists, labs, patients, employees, partners, dental networks and the global community.
As a leading dental provider, Straumann is renowned for innovation and quality backed by scientific evidence. To drive our mission further, Straumann and its partners have united to form the Straumann Group. By fostering international brands we raise quality and promote global excellence in dentistry. Based on a pioneering culture that promotes creativity and learning, we bring together: global reach, experience, legacy, innovative technology, and inspired professionals to increase confidence and enhance dental care worldwide. This strong legacy builds on close collaboration with leading clinics, institutes, universities, networks and communities. The Straumann Group researches, develops, manufactures and supplies dental implants, instruments, prosthetics, biomaterials and digital solutions for use in in tooth preservation, regeneration, restoration and replacement, in close and long-term collaboration with leading clinics, institutes, universities, networks and communities.
Headquartered in Basel, Switzerland, the Straumann Group employs approximately 4000 people worldwide. Its products, solutions and services are available in more than 100 countries through a broad network of distribution subsidiaries and partners, featuring the global brands Straumann, Neodent, Medentika, and other fully or partly-owned partner companies.
Key figures
(in CHF million)
2016 | 2015 | Change (%) | |
---|---|---|---|
Revenue | 918 | 799 | 15 |
Gross profit | 719 | 615 | 17 |
Operating profit | 227 | 173 | 32 |
Operating profit excl. exceptionals | 227 | 186 | 22 |
Net profit | 230 | 72 | 221 |
Net profit excl. exceptionals | 187 | 145 | 29 |
Cash generated from operating activities | 185 | 186 | (0) |
Capital expenditure | 46 | 35 | 33 |
Free cash flow | 139 | 151 | (8) |
Basic EPS (in CHF) | 14.68 | 4.52 | 225 |
Basic EPS (in CHF) excl. exceptionals |
11.94 | 9.19 | 30 |
Employees (at year end) | 3797 | 3471 | 9 |
Did you know?
1 second
Based on the volume of products sold, every second someone somewhere in the world is treated with a Straumann Group product.
20+ million
So far, more than 20 million Straumann brand implants have been placed worldwide.
97-100%
These are the survival and success rates of Straumann implants, based on several studies.*